ST Pharm
ST Pharm
01
Who we are
02
Our record
03
Newsroom
04
Contact
En
Ko
ST Pharm
Science & Technology
Business Overview
사업영역
CDMO
위탁생산개발
Small Molecule
Oligonucleotide
mRNA
CRO
위탁임상서비스
AnaPath Research & Service
R&D
연구개발
Virtual R&D
Global R&D
About
ST PHARM
핵심인력
연혁
Global 인증
자회사
CI
Public
PR (Public Relations)
News room
All
Media Focus
ST PHARM News
IR (Investor Relations)
Stock Information
IR Library
Disclosure Information
IR Materials
Notice
Careers
ESG
정도경영철학
사회적책임경영
인권경영
안전보건환경경영
준법경영
소비자중심경영
CSR
보고서
기업지배구조
Sitemap
Contact
Linkedin
Public
IR Materials
PR (Public Relations)
News room
All
Media Focus
ST PHARM News
IR (Investor Relations)
Stock Information
IR Library
Disclosure Information
IR Materials
Notice
IR Materials
Nov 19, 2024
[Update] 국문 IR 자료 입니다
2024년 3분기 보고서에 기반하여 업데이트 된 IR 및 실적 자료입니다
「반출」에스티팜_IR(24.11)_3.pdf
List